GLOBAL DIETARY SUPPLEMENT CDMO FOR TECH TRANSFER, MEDICAL R&D, AND SCALE
Olympia is a zero-conflict global CDMO built for enterprise buyers, PE-backed operators, and physician-led brands: evidence-based supplement formulation services, AI toxicology screening, and high-volume supplement contract manufacturing with full IP transfer.
STRUCTURAL ASYMMETRY · MANIFESTO §3
0 own consumer brands. 0 competing SKUs. 0 channel conflict.
OWN CONSUMER BRANDS
0
COMPETING SKUS HELD
0
EXCLUSIVITY CLAUSES VIOLATED, 17 YRS
0
RISK ELIMINATION · CLINICAL IP ARCHITECTURE
EVIDENCE-BASED SUPPLEMENT FORMULATION SERVICES FOR ENTERPRISE GROWTH AND EXIT READINESS.
Since 2009, Olympia Biosciences™ has operated as a global dietary supplement CDMO with zero consumer brands and zero conflict by design. Our programmes combine dietary supplement tech transfer, EU regulatory compliance strategy, pharmaceutical-grade analytics, and high-volume contract manufacturing — with 100% client IP ownership transfer as a contractual default.
YEARS - ZERO-COMPLAINT DISCIPLINE
QUALITY COMPLAINTS. EVER.
UNCONDITIONAL IP TRANSFER
INFORMATION SECURITY SHIELD
TRUST IS CHEAP. PUBLIC RECORDS ARE NOT.
Our authority is documented in auditable systems: Warsaw Stock Exchange filings naming Olympia alongside Lycotec, Adiuvo Investments, Symrise AG and Carocelle; scale-up of Cambridge spin-off technology; and NCBiR-patronised programmes. Compliance-grade proof, not marketing narrative.
Additional third-party validation includes Forbes coverage, the Rome International Award, and independent media scrutiny. Every core statement is anchored in legal, analytical, and capital-market documentation that any due-diligence team can verify before a call is even booked.
FOUNDER STATEMENT
“In an industry dominated by marketing noise and ready-made catalogue formulas, we engineer market phenomena backed by hard evidence. I will never be a businessperson pretending to be a scientist. I am a scientist managing a technological process to protect your medical reputation and your capital.”
Olimpia Baranowska
CEO & Scientific Director — IOC Ltd.
MOST-READ CLINICAL INTELLIGENCE — LIVE RANKING
Physicochemical Challenges in Alcohol-Free Sublingual Sprays: Solutions for Enhanced Stability and Bioavailability
Many people want sprays that deliver health benefits quickly by being absorbed under the tongue, especially without…
Major Advances in Rheumatology: 2025–2026 Breakthroughs
Treatments for chronic conditions where the body's own defense system mistakenly attacks itself, like lupus and art…
Thermodynamic Stability and Degradation Kinetics of Thermolabile Longevity Compounds Under High-Shear Manufacturing Stress
Many compounds believed to help us live longer and healthier are quite fragile. During manufacturing, processes lik…
A FORMULA WITHOUT PHYSICOCHEMICAL VALIDATION IS NOT A PRODUCT.
Many formulations that look viable on paper fail under real transport and storage stress. Without validated stability windows, suspensions crystallize, agglomerate, or separate under thermal gradients.
Fast quote cycles often model assumptions, not production reality. Paid Discovery executes feasibility diagnostics, AI safety screening, and Proof-of-Concept runs to establish a validated technical path before capital is committed.
PAID DISCOVERY — SCIENTIFIC CONTROL GATE
- > ELIMINATES NON-TECHNICAL BRIEFS AND PRICE-ONLY REQUESTS.
- > CONFIRMS SCIENTIFIC SCOPE, REGULATORY PATH, AND EXECUTION CAPACITY.
- > PRODUCES POC DATA, STABILITY DIRECTION, AND MANUFACTURING SPECIFICATION.
- > ESTABLISHES OLYMPIA AS SCIENTIFIC LEAD; ENGAGEMENT IS BY QUALIFICATION.
PILLAR 2 ECONOMICS · LIVE COMPOUND DRIFT
EVERY QUARTER YOU DELAY R&D, THE PROGRAMME COSTS MORE TO START.
We model effective programme cost as base R&D × (1 + 19.2%)^years, where the 19.2% rate combines CPI inflation (7.2%) with the CDMO risk buffer (12.0%) for raw material volatility, regulatory drift, and capacity scarcity. The drift compounds in real time below.
BASELINE R&D · TODAY
0.00%
COST IF YOU START IN 12 MONTHS
+19.20%
+19.2% DRIFT
DRIFT ACCRUED SINCE PAGE LOAD
+0.000000%
@ 19.2% / YR · COMPOUNDED PER SECOND
CLIENT R&D PLATFORM — ACTIVE ENGAGEMENTS ONLY
YOUR DEDICATED SCIENTIFIC COMMAND CENTER.
Every Paid Discovery client receives a private, encrypted portal with real-time access to their formulation intelligence: evidence architecture, dose-matched clinical citations, regulatory matrices, toxicology reports, interactive ingredient maps, and a direct encrypted channel to your R&D team. This is not a shared dashboard — it is your proprietary R&D command center with live communication.
EVIDENCE ARCHITECTURE
Every ingredient backed by dose-matched RCTs with direct DOI links. No hallucinated citations — only Elicit-verified studies at your exact formulation dose.
REGULATORY INTELLIGENCE
Multi-territory compliance matrices: EU (EFSA claims), US (FDA DSHEA), UAE (SFDA), with Novel Food status and maximum dose limits per jurisdiction.
TOXICOLOGY REPORTS
AI-powered safety screening with interaction matrices, contraindication flags, and BfR/EFSA upper limit verification for every active ingredient.
INTERACTIVE FORMULATION MAP
Visual ingredient relationship diagrams showing synergies, mechanism pathways, and claim architecture — filterable by SKU, mechanism, or regulatory status.
DOWNLOADABLE DATA ROOM
Full OB-branded document suite: screening reports, safety dossiers, evidence verification, and regulatory filings — all under your NDA, all yours to keep.
100% IP TRANSFER
Everything produced during Paid Discovery — formulas, data, reports, clinical mappings — transfers to you unconditionally. We retain zero rights to your science.
DIRECT ENCRYPTED CHANNEL — LIVE
Real-time encrypted messaging with your dedicated R&D team. No tickets. No queue. No third-party platform. Your messages reach the CEO and Lead Scientist directly — response within the same business day. End-to-end encrypted, ISO 27001 compliant, NDA-protected.
PORTAL ACCESS GRANTED UPON PAID DISCOVERY INITIATION
WE QUALIFY FOR SCIENTIFIC FIT BEFORE COMMERCIAL SCALE.
Paid Discovery is a deductible R&D deposit, not advisory theater. It includes feasibility diagnostics, AI toxicology screening, and Proof-of-Concept production. You receive technical documentation, stability direction, and unconditional 100% IP transfer under a zero-conflict operating model.
INITIATE R&D DUE DILIGENCE